Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Berberine can lower blood sugar on its own, and hypoglycemia becomes a real risk mainly when it is combined with insulin, sulfonylureas, or other glucose-lowering drugs, while rare cases of elevated liver enzymes and liver injury have been reported, especially at high doses or alongside medications processed by the liver. Warning signs worth taking seriously include shakiness, sweating, confusion, fainting, dark urine, yellowing skin or eyes, and persistent upper right abdominal pain. Dose, duration, existing liver or kidney conditions, and drug interactions all change your personal risk, so see below for the details that matter before you continue or stop taking it. Because these symptoms overlap with many other conditions, a free, instant, private online symptom check can help you sort out whether what you are feeling points to low blood sugar, a liver issue, or something unrelated. It takes about a minute, is doctor-developed, and gives you clear next steps plus questions to bring to a clinician.
Last reviewed for medical accuracy: 09/12/2026
Berberine is a natural compound found in several plants, including goldenseal, barberry, and Oregon grape. It’s gained attention for its potential benefits, especially in managing blood sugar and supporting metabolic health. However, as with any supplement, it’s important to understand possible risks—namely hypoglycemia (low blood sugar) and liver damage—and how to use berberine safely.
Berberine is an alkaloid that has been studied for various health effects:
Research into berberine includes randomized controlled trials, systematic reviews, and meta-analyses published in peer-reviewed journals. Always look for high-quality studies when evaluating supplement safety and effectiveness.
Most studies report that berberine safely lowers elevated blood sugar without causing severe hypoglycemia in healthy adults or those with mild to moderate type 2 diabetes. However, certain factors can increase your risk:
Be alert to symptoms of hypoglycemia, especially if you’re on diabetic medications:
If you experience these signs, check your blood sugar and treat with fast-acting carbohydrates (e.g., glucose tablets, fruit juice) as recommended by your healthcare provider.
Berberine has been studied for liver health, often showing protective effects in animal models of fatty liver disease. Human trials have generally not reported significant liver toxicity at common dosages (900–1,500 mg per day). However, rare cases of elevated liver enzymes have been documented, suggesting mild liver stress in sensitive individuals.
If you decide to take berberine:
To minimize risks and maximize benefits, follow these general recommendations:
Start Low, Go Slow
Take with Meals
Stay Hydrated
Avoid High-Risk Combinations
Monitor Blood Sugar
Monitor Liver Enzymes
Certain groups should talk to a healthcare professional before trying berberine:
Many clinical trials report that berberine effectively improves blood sugar, lipid profiles, and even weight management with a low incidence of severe side effects. That said, no supplement is risk-free. By understanding the mechanisms, watching for warning signs, and working with a healthcare provider, you can make an informed decision about whether berberine is right for you.
If you experience any of the following symptoms, seek prompt medical care:
For non-urgent concerns, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide if you need medical attention.
Remember: supplements can interact with medications and individual health conditions. Speak to a doctor before starting berberine, especially if you have diabetes, liver disease, or are taking other medications.
(References)
* Song D, Hao J, Fan D. Biological properties and clinical applications of berberine. Front Med. 2020 Oct;14(5):564-582. doi: 10.1007/s11684-019-0724-6. 2020 Apr 25. PMID: 32335802.
* Berberine. 2012. PMID: 33242239.
* Zhao MM, Lu J, Li S, Wang H, Cao X, Li Q, Shi TT, Matsunaga K, Chen C, Huang H, Izumi T, Yang JK. Berberine is an insulin secretagogue targeting the KCNH6 potassium channel. Nat Commun. 2021 Sep 23;12(1):5616. doi: 10.1038/s41467-021-25952-2. 2021 Sep 23. PMID: 34556670; PMCID: PMC8460738.
* Guo J, Chen H, Zhang X, Lou W, Zhang P, Qiu Y, Zhang C, Wang Y, Liu WJ. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxid Med Cell Longev. 2021;2021:2074610. doi: 10.1155/2021/2074610. 2021 Dec 15. PMID: 34956436; PMCID: PMC8696197.
* Xie W, Su F, Wang G, Peng Z, Xu Y, Zhang Y, Xu N, Hou K, Hu Z, Chen Y, Chen R. Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Front Pharmacol. 2022;13:1015045. doi: 10.3389/fphar.2022.1015045. 2022 Nov 16. PMID: 36467075; PMCID: PMC9709280.
* Zhu LR, Li SS, Zheng WQ, Ni WJ, Cai M, Liu HP. Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy. Front Immunol. 2023;14:1086078. doi: 10.3389/fimmu.2023.1086078. 2023 Feb 2. PMID: 36817459; PMCID: PMC9933143.
* Ji L, Ma J, Ma Y, Cheng Z, Gan S, Yuan G, Liu D, Li S, Liu Y, Xue X, Bai J, Wang K, Cai H, Li S, Liu K, Yu M, Liu L. Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2025 Mar 3;8(3):e2462185. doi: 10.1001/jamanetworkopen.2024.62185. 2025 Mar 3. PMID: 40029660; PMCID: PMC11877176.
* Cha HR, Kim JS, Ryu JH, Cho HJ. Investigating Neuroprotective Effects of Berberine on Mitochondrial Dysfunction and Autophagy Impairment in Parkinson's Disease. Int J Mol Sci. 2025 Jul 29;26(15). doi: 10.3390/ijms26157342. 2025 Jul 29. PMID: 40806472; PMCID: PMC12346907.
* Tao X, Gao Y, Jin Z, Lu S, Li Z, Guo S, Fan Q, Li J, Qiao C, Lei H, Zhang Z, Zhao C, Wu J. Co-administration of berberine and evodiamine: Mitigating evodiamine-induced hepatotoxicity and potentiating colitis treatment. Phytomedicine. 2025 Nov;147:157185. doi: 10.1016/j.phymed.2025.157185. 2025 Aug 20. PMID: 40865345.
* Zhang Q, Li N, Ma X, Qiu Y, Li C, Chen Y. Berberine protects against gefitinib-induced liver injury by inhibiting the HMGB1/TLR4/NF-κB pathway. Front Pharmacol. 2025;16:1645634. doi: 10.3389/fphar.2025.1645634. 2025 Aug 26. PMID: 40932871; PMCID: PMC12417729.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.